Series
The 5th ELSI Congress - ELSIcon2022
ELSIcon2022 Flash: Distributional Cost-Effectiveness Analysis to Incorporate Health Equity Concerns in the Assessment of the Value of Precision Medicine Technologies
Type
Conference

ELSIcon2022 • Flash • May 31, 2022

Cheng Chen, Jeroen Jansen

BACKGROUND: Distributional cost-effectiveness analysis (DCEA) has been recently proposed as an intuitive extension of conventional cost-effectiveness analysis to examine health equity impacts of health care interventions. A DCEA provides relevant information for policy-makers that not only aim to improve total health but are concerned about inequality in health outcomes as well. However, the use of DCEA has been limited, especially in the context of precision medicine.


OBJECTIVE: To illustrate DCEA with an example evaluation of the use of liquid biopsy to inform first-line targeted therapy for advanced non-small cell lung cancer (NSCLC).

METHODS: We developed a decision model to compare expected outcomes and costs for the scenarios with and without liquid biopsy based on currently available evidence. The distributions of the modeled health outcomes, taking into consideration the opportunity costs, were compared in terms of average health and health inequality across different social subgroups of interest. 

RESULTS: Our evaluation showed for which clinical scenarios the use of liquid biopsy to inform treatment decisions has value and whether baseline disparities in NSCLC outcomes are likely to be reduced or exacerbated. The analysis also highlighted a primary challenge with a DCEA of a new technology: gaps in the evidence base regarding test performance and treatment effects in minority populations.

CONCLUSIONS: Despite uncertainty in the estimated health equity impact of a new health technology due to gaps in the evidence base, pursuing a DCEA is worthwhile as it contributes to more honest policy discussions regarding health equity in relation to precision medicine.

Tags

Keywords
Live
Flash
tools
Health Disparities

Videos in Series

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 12

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Flash Session 2

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Moderated Plenary Panel

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 14

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 13

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 17

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 15

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: Fresh Air for Genetic Data Sharing

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 11

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 10

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 9

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 8

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 7

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Trainee Networking Session: Working with NHGRI

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: Diversity’s Pandemic Distractions

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 6

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 5

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 3

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 2

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 1

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Flash Session 1

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022: Paper Session 4

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: ELSI and the New Precision Stewards?

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: Toward an anthropology of rare disease

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: In the Shadows of Virtual Family Trees

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: The ELSI of Pandemic Biobanking

The 5th ELSI Congress - ELSIcon2022 - ELSIcon2022 Paper: Whose future should we worry about?

Related Videos